July 22, 2021
New 20/15 Visioneers and Eagle Genomics Partnership to Promote Global Microbiome Education and Standardization New joint white paper demonstrates fundamental role of microbiome in ongoing “Bio Revolution” and Causal network science to be critical tool for translating highly-complex, multi-dimensional microbiome data into actionable insights. Hereford, Pennsylvania, USA & Cambridge, UK - Today, 20/15 Visioneers LLC. (20/15), a [...]
July 22, 2021
SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) today affirmed its commitment to re-acquire GRAIL, a healthcare company focused on multi-cancer early detection. “This acquisition is procompetitive, and we have offered far-reaching structural and behavioral remedies to address any potential concerns. Illumina will continue to work with the European Commission (EC) to ensure that it has [...]
July 22, 2021
RADNOR, Pa. -- Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences, advanced technologies and applied materials industries, today published its first sustainability report. The report highlights key actions taken in 2020, as well as initiatives underway to accelerate future sustainability goals that advance the Company's [...]
SOPHiA GENETICS Announces Pricing of Initial Public Offering
July 22, 2021
BOSTON and LAUSANNE, Switzerland -- SOPHiA GENETICS SA, the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today the pricing of its initial public offering of 13,000,000 ordinary shares at a price of $18 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions [...]
July 22, 2021
MARS® Systems and MARS® MAG Line purifies target cells in a rapid, automated, flexible process with a cost-effective solution. SANTA CLARA, CA, USA -- Applied Cells, a provider of cell preparation and isolation solutions for tumor and immune biology research, today announced the release of its MARS® MAG Line. Developed to support the expansion of turnkey applications [...]
July 22, 2021
New joint white paper demonstrates fundamental role of microbiome in ongoing “Bio Revolution” and Causal network science to be critical tool for translating highly-complex, multi-dimensional microbiome data into actionable insights. Hereford, Pennsylvania, USA & Cambridge, UK - Today, 20/15 Visioneers LLC. (20/15), a leading computational and scientific informatics management consulting and marketing company, and Eagle Genomics Ltd. (Eagle), a leading global microbiome data and analytics company, announced a new partnership, focused on raising awareness of improved microbiome [...]
July 21, 2021
Alliance to expand the range of therapeutic and vaccine applications for the BioXp™ system SAN DIEGO -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), for its industry-leading CleanCap® technology. Codex DNA will integrate [...]
OncoArendi licenses Cresset molecule design software to advance the development of new therapeutics
July 21, 2021
Cambridge, UK – 21 July 2021 – Cresset, innovative provider of outstanding software for molecule discovery and design, is pleased to announce that OncoArendi Therapeutics SA (WSE: OAT), a biotechnology company which specializes in the discovery and development of new drugs, has licensed Flare™ for use in its internal development programs. Cresset software uses its proprietary descriptors of [...]
Nanalysis Acquires New York Based Software Company
July 21, 2021
CALGARY, AB - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, OTCQX: NSCIF, FRA: 1N1), is pleased to announce that it has acquired 100 percent of One Moon Scientific ("OMS"), a New York based magnetic resonance software company. This acquisition opens up new industry verticals for hardware sales and allows for software licensing and SAAS revenue. One Moon Scientific specializes in a suite of [...]
Codex DNA Announces Licensing and Supply Deal with TriLink Biotechnologies for CleanCap® mRNA …
July 21, 2021
SAN DIEGO -- Codex DNA, Inc. (NASDAQ: DNAY), a pioneer in automated benchtop synthetic biology systems, today announced a licensing and supply agreement with TriLink Biotechnologies, part of Maravai LifeSciences (NASDAQ: MRVI), for its industry-leading CleanCap® technology. Codex DNA will integrate the mRNA capping technology into its suite of automated mRNA synthesis kits for the [...]

